This information is not a substitute for professional medical advice
12 There is insufficient evidence to compare the effectiveness of cryotherapy with imiquimod for the treatment of superficial BCC
Management Strategies for Gastrointestinal Adverse Events with GLP-1RA Therapy There are various strategies that can be employed to help manage or mitigate potential gastrointestinal adverse events when initiating a GLP-1RA for the treatment of overweight or obesity
Gonzlez-Garca I, Gruber T, Garca-Cceres C
Likewise, once a week administration of efpeglenatide, a long acting GLP-1RA, significantly reduced the body weight in obese patients (172)
While this is just a small sampling of the community, I wanted to share the results beyond our community because they echo other small studies reporting potential benefits for HS patients and support the case for further research on HS and GLP-1s